726 related articles for article (PubMed ID: 28740372)
1. Pharmacological treatment of osteoporosis in the oldest old.
Vandenbroucke A; Luyten FP; Flamaing J; Gielen E
Clin Interv Aging; 2017; 12():1065-1077. PubMed ID: 28740372
[TBL] [Abstract][Full Text] [Related]
2. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.
Lin X; Xiong D; Peng YQ; Sheng ZF; Wu XY; Wu XP; Wu F; Yuan LQ; Liao EY
Clin Interv Aging; 2015; 10():1017-33. PubMed ID: 26150706
[TBL] [Abstract][Full Text] [Related]
4. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.
Jansen JP; Bergman GJ; Huels J; Olson M
Semin Arthritis Rheum; 2011 Feb; 40(4):275-84.e1-2. PubMed ID: 20828791
[TBL] [Abstract][Full Text] [Related]
7. Update on osteoporosis treatment.
Nogués X; Martinez-Laguna D
Med Clin (Barc); 2018 Jun; 150(12):479-486. PubMed ID: 29179892
[TBL] [Abstract][Full Text] [Related]
8. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Pignone M; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2018 Jun; 319(24):2521-2531. PubMed ID: 29946735
[TBL] [Abstract][Full Text] [Related]
9. Prevention of osteoporotic fractures in the elderly.
Wilkins CH; Birge SJ
Am J Med; 2005 Nov; 118(11):1190-5. PubMed ID: 16271899
[TBL] [Abstract][Full Text] [Related]
10. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
[TBL] [Abstract][Full Text] [Related]
11. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
12. Treatment of osteoporosis: current state of the art.
Hamrick I; Schrager S; Nye AM
Wien Med Wochenschr; 2015 Feb; 165(3-4):54-64. PubMed ID: 25502850
[TBL] [Abstract][Full Text] [Related]
13. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
[TBL] [Abstract][Full Text] [Related]
14. Rates of osteoporosis screening and treatment following vertebral fracture.
Barton DW; Behrend CJ; Carmouche JJ
Spine J; 2019 Mar; 19(3):411-417. PubMed ID: 30142455
[TBL] [Abstract][Full Text] [Related]
15. The clinician's guide to prevention and treatment of osteoporosis.
LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES
Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046
[TBL] [Abstract][Full Text] [Related]
16. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY
Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis in premenopausal women.
Langdahl BL
Curr Opin Rheumatol; 2017 Jul; 29(4):410-415. PubMed ID: 28394826
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Treatment of Osteoporosis.
O'Connor KM
Med Clin North Am; 2016 Jul; 100(4):807-26. PubMed ID: 27235616
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, effectiveness and side effects of medications used to prevent fractures.
Reid IR
J Intern Med; 2015 Jun; 277(6):690-706. PubMed ID: 25495429
[TBL] [Abstract][Full Text] [Related]
20. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
